Use of bone marrow mesenchymal stem cells for ex vivo cartilage regeneration;Einsatz von mesenchymalen knochenmarkstammzellen für die ex-vivo-knorpelregeneration

Orthopade

Volumn 36, Issue 3, 2007, Pages 227-235

  Grassel S ^a,b   Ahmed, N ^a,b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Articular cartilage; Chondroprogenitor cells; Mesenchymal stem cells; Regenerative medicine; Regulatory factors

Indexed keywords

ARTHRALGIA; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE INJURY; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; FIBROCARTILAGE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYALINE CARTILAGE; JOINT PROSTHESIS; JOINT STABILITY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MORBIDITY; QUALITY OF LIFE; TISSUE ENGINEERING; TISSUE REGENERATION;

BONE MARROW TRANSPLANTATION; CARTILAGE; CARTILAGE DISEASES; FRACTURES, CARTILAGE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; PHYSICIAN'S PRACTICE PATTERNS; TISSUE ENGINEERING;

EID: 33947512668     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-007-1058-7     Document Type: Article

References (44)

1. Ahmed N, Dreier R, Göpferich A et al. (2006) Soluble signalling factors from differentiated cartilage tissue affect chondrogenic differentiation in adult mesenchymal stem cells. Arthris Res Ther (submitted)
2. Ahmed N, Vogel B, Rohde E et al. (2006) CD45-positive cells of haematopoietic origin enhance chondrogenic marker gene expression in rat marrow stromal cells. Int J Mol Med 18: 233-240
3. Babarina AV, Mollers U, Bittner K et al. (2001) Role of the subchondral vascular system in endochondral ossification: endothelial cell-derived proteinases derepress late cartilage differentiation in vitro. Matrix Biol 20: 205-213
4. Barry FP (2003) Biology and clinical applications of mesenchymal stem cells. Birth Defects Res C Embryo Today 69: 250-256
5. Bi W, Deng JM, Zhang Z et al. (1999) Sox9 is required for cartilage formation. Nat Genet 22: 85-89
6. Bianco P, Riminucci M, Gronthos S, Robey PG (2001) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19: 180-192
7. Bianco P, Robey PG (2001) Stem cells in tissue engineering. Nature 414: 118-121
8. Bittner K, Vischer P, Bartholmes P, Bruckner P (1998) Role of the subchondral vascular system in endochondral ossification: endothelial cells specifically derepress late differentiation in resting chondrocytes in vitro. Exp Cell Res 238: 491-497
9. Brittberg M, Lindahl A, Nilsson A et al. (1994) Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331: 889-895
10. Cancedda R, Dozin B, Giannoni P, Quarto R (2003) Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 22: 81-91
11. Caplan AI (2005) Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 11: 1198-1211
12. Caplan AI, Bruder SP (2001) Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7: 259-264
13. Delles AM, Rittenhouse-Olson K, Morgan J, Oseroff AR (2002) A simple method for the purification of human peripheral blood antigen presenting cells (dendritic cells, monocytes/macrophages, and B lymphocytes). Immunol Invest 31: 233-245
14. Dorshkind K (1990) Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8: 111-137
15. Dreier R, Grassel S, Fuchs S et al. (2004) Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. Exp Cell Res 297: 303-312
16. Friedenstein AJ, Gorskaja JF, Kulagina NN (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4: 267-274
17. Furumatsu T, Tsuda M, Taniguchi N et al. (2005) Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J Biol Chem 280: 8343-8350
18. Gerber HP, Vu TH, Ryan AM et al. (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623-628
19. Goldring MB, Tsuchimochi K, Ijiri K (2006) The control of chondrogenesis. J Cell Biochem 97: 33-44
20. Harada S, Sampath TK, Aubin JE, Rodan GA (1997) Osteogenic protein-1 up-regulation of the collagen X promoter activity is mediated by a MEF-2-like sequence and requires an adjacent AP-1 sequence. Mol Endocrinol 11: 1832-1845
21. Inada M, Yasui T, Nomura S et al. (1999) Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214: 279-290
22. Jikko A, Kato Y, Hiranuma H, Fuchihata H (1999) Inhibition of chondrocyte terminal differentiation and matrix calcification by soluble factors released by articular chondrocytes. Calcif Tissue Int 65: 276-279
23. Johansson N, Saarialho-Kere U, Airola K et al. (1997) Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 208: 387-397
24. Knauper V, Bailey L, Worley JR et al. (2002) Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13. FEBS Lett 532: 127-130
25. Knauper V, Cowell S, Smith B et al. (1997) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 272: 7608-7616
26. Knauper V, Lopez-Otin C, Smith B et al. (1996) Biochemical characterization of human collagenase-3. J Biol Chem 271: 1544-1550
27. Lefebvre V, Behringer RR, Crombrugghe B de (2001) L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 9(Suppl A): 69-75
28. Majumdar MK, Thiede MA, Mosca JD et al. (1998) Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176: 57-66
29. Matsushita K, Motani R, Sakuta T et al. (2000) The role of vascular endothelial growth factor in human dental pulp cells: induction of chemotaxis, proliferation, and differentiation and activation of the AP-1-dependent signaling pathway. J Dent Res 79: 1596-1603
30. Mitchell PG, Magna HA, Reeves LM et al. (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97: 761-768
31. Moore KA, Lemischka IR (2006) Stem cells and their niches. Science 311: 1880-1885
32. Pfander D, Kortje D, Zimmermann R et al. (2001) Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis 60: 1070-1073
33. Pittenger MF, Mackay AM, Beck SC et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147
34. Porte D, Tuckermann J, Becker M et al. (1999) Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 18: 667-678
35. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74
36. Pufe T, Harde V, Petersen W et al. (2004) Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J Pathol 202: 367-374
37. Pufe T, Petersen W, Tillmann B, Mentlein R (2001) The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 44: 1082-1088
38. Riemer S, Gebhard S, Beier F et al. (2002) Role of c-fos in the regulation of type X collagen gene expression by PTH and PTHrP: localization of a PTH/PTHrP-responsive region in the human COL10A1 enhancer. J Cell Biochem 86: 688-699
39. Solchaga LA, Welter JF, Lennon DP, Caplan AI (2004) Generation of pluripotent stem cells and their differentiation to the chondrocytic phenotype. Methods Mol Med 100: 53-68
40. Uusitalo H, Hiltunen A, Ahonen M et al. (2001) Accelerated up-regulation of L-Sox5, Sox6, and Sox9 by BMP-2 gene transfer during murine fracture healing. J Bone Miner Res 16: 1837-1845
41. Mark MK von der, Kirsch T, Nerlich A et al. (1992) Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum 35: 806-811
42. Wu CW, Tchetina EV, Mwale F et al. (2002) Proteolysis involving matrix metalloproteinase 13 (collagenase-3) is required for chondrocyte differentiation that is associated with matrix mineralization. J Bone Miner Res 17: 639-651
43. Yin M, Pacifici M (2001) Vascular regression is required for mesenchymal condensation and chondrogenesis in the developing limb. Dev Dyn 222: 522-533
44. Zerega B, Cermelli S, Bianco P et al. (1999) Parathyroid hormone [PTH(1-34)] and parathyroid hormone-related protein [PTHrP(1-34)] promote reversion of hypertrophic chondrocytes to a prehypertrophic proliferating phenotype and prevent terminal differentiation of osteoblast-like cells. J Bone Miner Res 14: 1281-1289